Metronidazole USP For Compounding (API)

Metronidazole USP For Compounding (API) is an essential active ingredient used for formulating medications that treat a variety of bacterial and protozoal infections. It is commonly utilized in the treatment of conditions such as bacterial vaginosis, trichomoniasis, and certain gastrointestinal and skin infections. Known for its antimicrobial properties, Metronidazole effectively targets anaerobic bacteria and protozoa, making it a versatile component in infection management. Compounded formulations allow healthcare professionals to tailor doses for optimal efficacy and patient-specific needs. Adhering to stringent pharmaceutical standards, Metronidazole supports customized therapeutic strategies and antimicrobial stewardship, promoting overall health and wellness.

Metronidazole USP active pharmaceutical ingredient (API) is a synthetic antibiotic and antiprotozoal drug. It is used to treat various infections caused by bacteria and protozoa, including dental, respiratory, skin and gastrointestinal infections. Metronidazole works by inhibiting the growth and replication of bacterial and protozoal cells, ultimately leading to their death.

Metronidazole is also used in the treatment of certain sexually transmitted infections, including trichomoniasis, and is a common medication used to prevent infections during surgical procedures. It may also be used in combination with other drugs to treat certain types of stomach ulcers.

As an API, Metronidazole USP is manufactured under strict quality standards and guidelines to ensure its safety, effectiveness and purity. It is supplied in various forms, including tablets, capsules, creams, gels, solutions and injections.

Metronidazole has been approved by the FDA (Food and Drug Administration) and is a widely used and well-tolerated medication. It is available both as a prescription and over-the-counter drug in many countries.

CAS Number: 443-48-1

Property: Light Sensitive | Hazardous Material